Blueprint Health appeared to be the Corporate Investor, which was created in 2011. The fund was located in North America if to be more exact in United States. The main department of described Corporate Investor is located in the New York.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Blueprint Health, startups are often financed by United Talent Agency, USC Viterbi Startup Garage, StartUp Health. The meaningful sponsors for the fund in investment in the same round are Valence Ventures, Silicon Badia, Ballpark Ventures. In the next rounds fund is usually obtained by Hudson River Capital Partners, Dreamit Ventures, Newark Venture Partners.
The fund was created by Brad Weinberg, Mathew Farkash.
The fund has no exact preference in some founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. Besides, a startup needs to be aged 1 and less years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Health Care, Software. Among the various public portfolio startups of the fund, we may underline Artemis Health, AdhereTech, MediQuire
Opposing the other organizations, this Blueprint Health works on 23 percentage points less the average amount of lead investments. The top amount of exits for fund were in 2020. The real fund results show that this Corporate Investor is 18 percentage points less often commits exit comparing to other companies. When the investment is from Blueprint Health the average startup value is 1-5 millions dollars. The common things for fund are deals in the range of 100 thousands - 1 million dollars. The fund is generally included in 7-12 deals every year. The important activity for fund was in 2013.
Related Funds
Funds with similar focus
Fund Name | Location |
9+ Program | California, Menlo Park, United States |
Alvogen | New Jersey, Pine Brook, United States |
B3Forin | - |
Colchis Capital Management | California, San Francisco, United States |
Columbia Records | New York, New York, United States |
Crocker Mountain Capital | - |
Devoteam | France, Ile-de-France, Levallois-perret |
Epic Games | Cary, North Carolina, United States |
Hengqin Financial Investment | - |
House of Fraser | England, London, United Kingdom |
Innov8on | Mazowieckie, Poland, Warsaw |
Northwood Ventures | New York, Syosset, United States |
RTP Partners | - |
ShareLink Capital | China, Shanghai |
Skayle | Central, Central Region, Singapore |
Weiji Investment | China, Guangdong, Shenzhen |
Yoma Bank | Myanmar, Yangon, Yangon |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Pathology Watch | $25M | 16 Nov 2021 | Utah, United States | ||
Blue Mesa Health | $1M | 24 Jul 2017 | New York, New York, United States | ||
Rappora | 01 May 2016 | Austin, Texas, United States | |||
MedPilot | $750K | 06 Apr 2016 | Cleveland, Ohio, United States | ||
MediQuire | $4M | 04 Apr 2016 | New York, New York, United States | ||
NexHealth | $20K | 06 Feb 2016 | San Francisco, California, United States | ||
Psocratic, Inc. | 16 Jul 2015 | New York, New York, United States | |||
DocDelta | $20K | 01 Jul 2015 | United States, New York | ||
TapGenes | $20K | 05 Feb 2015 | Chicago, Illinois, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Pathology Watch | $25M | 16 Nov 2021 | Utah, United States | ||
Blue Mesa Health | $1M | 24 Jul 2017 | New York, New York, United States | ||
Rappora | 01 May 2016 | Austin, Texas, United States | |||
MedPilot | $750K | 06 Apr 2016 | Cleveland, Ohio, United States | ||
MediQuire | $4M | 04 Apr 2016 | New York, New York, United States | ||
NexHealth | $20K | 06 Feb 2016 | San Francisco, California, United States | ||
Psocratic, Inc. | 16 Jul 2015 | New York, New York, United States | |||
DocDelta | $20K | 01 Jul 2015 | United States, New York | ||
TapGenes | $20K | 05 Feb 2015 | Chicago, Illinois, United States |